OBJECTIVE: It was to investigate visual field (VF) abnormalities in a group of multiple sclerosis (MS) patients in the remission phase and the presence of magnetic resonance imaging (MRI) lesions in the optic radiations. METHODS: VF was assessed in 60 participants (age range 20-51 years): 35 relapsing-remitting MS patients [20 optic neuritis (+), 15 optic neuritis (-)] and 25 controls. MRI (3-Tesla) was obtained in all patients. RESULTS: Visual parameters were abnormal in MS patients as compared to controls. The majority of VF defects were diffuse. All patients except one had posterior visual pathways lesions. No significant difference in lesion number, length and distribution was noted between patients with and without history of optic neuritis. One patient presented homonymous hemianopsia. CONCLUSION: Posterior visual pathway abnormalities were found in most MS patients despite history of previous optic neuritis.
OBJECTIVE: It was to investigate visual field (VF) abnormalities in a group of multiple sclerosis (MS) patients in the remission phase and the presence of magnetic resonance imaging (MRI) lesions in the optic radiations. METHODS: VF was assessed in 60 participants (age range 20-51 years): 35 relapsing-remitting MSpatients [20 optic neuritis (+), 15 optic neuritis (-)] and 25 controls. MRI (3-Tesla) was obtained in all patients. RESULTS: Visual parameters were abnormal in MSpatients as compared to controls. The majority of VF defects were diffuse. All patients except one had posterior visual pathways lesions. No significant difference in lesion number, length and distribution was noted between patients with and without history of optic neuritis. One patient presented homonymous hemianopsia. CONCLUSION: Posterior visual pathway abnormalities were found in most MSpatients despite history of previous optic neuritis.
Authors: Santiago Ortiz-Perez; Magí Andorra; Bernardo Sanchez-Dalmau; Rubén Torres-Torres; David Calbet; Erika J Lampert; Salut Alba-Arbalat; Ana M Guerrero-Zamora; Irati Zubizarreta; Nuria Sola-Valls; Sara Llufriu; María Sepúlveda; Albert Saiz; Pablo Villoslada; Elena H Martinez-Lapiscina Journal: J Neurol Date: 2016-02-09 Impact factor: 4.849
Authors: E J Lampert; M Andorra; R Torres-Torres; S Ortiz-Pérez; S Llufriu; M Sepúlveda; N Sola; A Saiz; B Sánchez-Dalmau; P Villoslada; Elena H Martínez-Lapiscina Journal: J Neurol Date: 2015-08-11 Impact factor: 4.849
Authors: Elena H Martínez-Lapiscina; Elena Fraga-Pumar; Iñigo Gabilondo; Eloy Martínez-Heras; Ruben Torres-Torres; Santiago Ortiz-Pérez; Sara Llufriu; Ana Tercero; Magi Andorra; Marc Figueras Roca; Erika Lampert; Irati Zubizarreta; Albert Saiz; Bernardo Sanchez-Dalmau; Pablo Villoslada Journal: BMC Res Notes Date: 2014-12-15
Authors: M Satue; L Jarauta; J Obis; M Cipres; M J Rodrigo; C Almarcegui; I Dolz; J R Ara; J Martin; L E Pablo; E Garcia-Martin Journal: J Ophthalmol Date: 2019-09-18 Impact factor: 1.909